Table 1.
Patient characteristics and summarized PSMA PET findings
| Age: | ||
| Median | 67 | |
| IQR | 61–71 | |
| No. race (%): | ||
| White | 95 | (88.0) |
| Nonwhite | 13 | (12.0) |
| PSA (ng/ml): | ||
| Median | 0.7 | |
| IQR | 0.3–1.8 | |
| No. ng/ml PSA categorical (%): | ||
| 0.5 or Less | 46 | (42.6) |
| Greater than 0.5–2.0 | 23 | (21.3) |
| Greater than 2.0 | 39 | (36.1) |
| No. mos PSADT (%):* | ||
| Less than 9/9 or more | 43 | (46.7)/49 (53.3) |
| Less than 12/12 or more | 52 | (56.5)/40 (43.5) |
| No. Gleason sum (%): | ||
| 7 or Less | 76 | (70.4) |
| 8 or Greater | 29 | (26.8) |
| Unknown | 3 | (2.8) |
| No. PSMA imaging result (%): | ||
| Pos | 82 | (75.9) |
| Neg | 26 | (24.1) |
| No. pelvic confined disease (%):† | ||
| Yes | 50 | (61) |
| No | 32 | (39) |
*
In 92.
†
In 82, positive only.